Biologic effects of the transfected Transmembrane TNF-α-intracellular domain on human breast tumor cell line MCF-7
QIN Na-lin,YIN Bing-jiao,WANG Ni-dan,ZHU Jian-hua,PANG Yan,JIANG Xiao-dan,FENG Wei,LI Zhuo-ya
DOI: https://doi.org/10.3969/j.issn.1000-8861.2007.06.006
2007-01-01
Abstract:Objective To establish the MCF-7 cell line which express transmembrane (TM)-TNF-α intracellular domain (TNF-ICD) protein stably and highly, and to investigate the reverse signaling of TM-TNF-α. Methods The vector of pIRES2-EGFP, which contained human TNF-ICD cDNA, was transduced into a human breast tumor cell line MCF-7 with Lipofectamine 2000. The positive cell clone expressing TNF-ICD protein was detected with indirect immunofluorescence method and flow cytometry. The cytotoxicity of TNF-α against the MCF-7 cells expressing TNF-ICD was determined by bioassay. NO production and NF-κB activity were detected by ELISA method. Results The MCF-7 cells transfected with the TNF-ICD gene could express high lever of TNF-ICD protein, which was confirmed by immunofluorescence and FACS. Bioassay shown that the MCF-7 cells expressing TNF-ICD was resisted to the cytotoxicity of TNF-α. The NO production and NF-κB activity of the transfected cells increased significantly. PDTC, a NF-κB inhibitor, could restore efficiently the sensibility of TNF-ICD-transfected MCF-7 cells to TNF-α. Conclusion The establishment of tumor cell line MCF-7 expressing TNF-ICD gene provide a good model for further studying reverse signaling of TM-TNF-α. TM-TNF-α intracellular domain (-76-1) may be an active domain which involved in the reverse signaling of TM-TNF-α, stimulating NF-κB, and resisting to the cytotoxicity of TNF-α.